BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11553813)

  • 1. Chemosensitivity prediction by transcriptional profiling.
    Staunton JE; Slonim DK; Coller HA; Tamayo P; Angelo MJ; Park J; Scherf U; Lee JK; Reinhold WO; Weinstein JN; Mesirov JP; Lander ES; Golub TR
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10787-92. PubMed ID: 11553813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrative genomic and proteomic approach to chemosensitivity prediction.
    Ma Y; Ding Z; Qian Y; Wan YW; Tosun K; Shi X; Castranova V; Harner EJ; Guo NL
    Int J Oncol; 2009 Jan; 34(1):107-15. PubMed ID: 19082483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting cancer drug response by proteomic profiling.
    Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
    Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity.
    Hsu YC; Chen HY; Yuan S; Yu SL; Lin CH; Wu G; Yang PC; Li KC
    BMC Med; 2013 Apr; 11():106. PubMed ID: 23590835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
    Nakatsu N; Yoshida Y; Yamazaki K; Nakamura T; Dan S; Fukui Y; Yamori T
    Mol Cancer Ther; 2005 Mar; 4(3):399-412. PubMed ID: 15767549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
    Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
    Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current progress in the prediction of chemosensitivity for breast cancer.
    Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Shimada H
    Breast Cancer; 2004; 11(1):42-8. PubMed ID: 14718792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
    Jung JJ; Jeung HC; Chung HC; Lee JO; Kim TS; Kim YT; Noh SH; Rha SY
    Genomics; 2009 Jan; 93(1):52-61. PubMed ID: 18804159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.
    Dan S; Tsunoda T; Kitahara O; Yanagawa R; Zembutsu H; Katagiri T; Yamazaki K; Nakamura Y; Yamori T
    Cancer Res; 2002 Feb; 62(4):1139-47. PubMed ID: 11861395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
    Dressman HK; Berchuck A; Chan G; Zhai J; Bild A; Sayer R; Cragun J; Clarke J; Whitaker RS; Li L; Gray J; Marks J; Ginsburg GS; Potti A; West M; Nevins JR; Lancaster JM
    J Clin Oncol; 2007 Feb; 25(5):517-25. PubMed ID: 17290060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A community effort to assess and improve drug sensitivity prediction algorithms.
    Costello JC; Heiser LM; Georgii E; Gönen M; Menden MP; Wang NJ; Bansal M; Ammad-ud-din M; Hintsanen P; Khan SA; Mpindi JP; Kallioniemi O; Honkela A; Aittokallio T; Wennerberg K; ; Collins JJ; Gallahan D; Singer D; Saez-Rodriguez J; Kaski S; Gray JW; Stolovitzky G
    Nat Biotechnol; 2014 Dec; 32(12):1202-12. PubMed ID: 24880487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
    Yabuki N; Sakata K; Yamasaki T; Terashima H; Mio T; Miyazaki Y; Fujii T; Kitada K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):1-9. PubMed ID: 17284363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.
    Györffy B; Surowiak P; Kiesslich O; Denkert C; Schäfer R; Dietel M; Lage H
    Int J Cancer; 2006 Apr; 118(7):1699-712. PubMed ID: 16217747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitivity prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data.
    Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Noguchi T; Kawahara K; Natsugoe S; Aikou T; Okazaki Y; Hayashizaki Y; Sato Y; Todo S; Hiyama E; Nishiyama M
    Int J Oncol; 2006 May; 28(5):1153-62. PubMed ID: 16596231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays.
    Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Danenberg PV; Shimada H
    Int J Oncol; 2005 Aug; 27(2):371-6. PubMed ID: 16010417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.
    Havaleshko DM; Smith SC; Cho H; Cheon S; Owens CR; Lee JK; Liotta LA; Espina V; Wulfkuhle JD; Petricoin EF; Theodorescu D
    Neoplasia; 2009 Nov; 11(11):1185-93. PubMed ID: 19881954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity.
    Zhang JT
    Cell Res; 2007 Apr; 17(4):311-23. PubMed ID: 17404598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-platform, multi-site, microarray-based human tumor classification.
    Bloom G; Yang IV; Boulware D; Kwong KY; Coppola D; Eschrich S; Quackenbush J; Yeatman TJ
    Am J Pathol; 2004 Jan; 164(1):9-16. PubMed ID: 14695313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.
    Quintieri L; Fantin M; Vizler C
    Adv Exp Med Biol; 2007; 593():95-104. PubMed ID: 17265720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of replacing the unreliable cDNA microarray measurements on the disease classification based on gene expression profiles and functional modules.
    Wang D; Lv Y; Guo Z; Li X; Li Y; Zhu J; Yang D; Xu J; Wang C; Rao S; Yang B
    Bioinformatics; 2006 Dec; 22(23):2883-9. PubMed ID: 16809389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.